ture. Bactericidal activity in vivo is resultant of its binding to essential target proteins, termed the penicillin-binding proteins, which are located in the bacterial cell wall. Inhibition of these proteins leads to bacterial cell wall elongation and leakage, thus the bacteria are unable to divide and mature, z PHARMACOKI N ETICS Cefuroxime axetil is available as a tablet and a flavored suspension. Although the tablets have undergone three product reformulations in an attempt to standardize absorption, the bioavailability issues have been resolved with the currently marketed tablet. Cefuroxime axetil is converted to the active moiety, cefuroxime, in less than 3 min once absorbed. Due to the rapid conversion it is not possible to detect cefuroxime axetil in the systemic circulation. Peak serum concentration achieved after a single 250 mg dose in the fed state is 4.7 mcg/ml and is reached after 2.1 h post-ingestion. 3 The administration of food with cefuroxime axetil substantially increases its absorption. extended in patients with renal dysfunction (see Table 1 ). 
SIDE EFFECTS AND INTERACTIONS

CONCLUSIONS
Cefuroxime axetil is a broad spectrum 13-1actam antibiotic. It has many approved indications, however, it is considered a second-line alternative. It is not the drug of choice for any infection, particularly those encountered in the field of obstetrics and gynecology. It is safe to use in pregnancy and has a low adverse effect profile, but due to its excessive acquisition cost and better therapeutic alternatives, it should be reserved for select cases.
